Apr 25, 2024 / 06:00AM GMT
Presentation
Apr 25, 2024 / 06:00AM GMT
=====================
Corporate Participants
=====================
* Hiroyuki Okuzawa
Daiichi Sankyo Company, Limited - President, COO & Representative Director
* Ken Takeshita
Daiichi Sankyo Company, Limited - Head of Research & Development Unit
* Koji Ogawa
Daiichi Sankyo Company, Limited - Managing Executive Officer, Head of Global Corporate Planning & Management and CFO
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc., Research Division - MD, Analyst & Head of Pan-Asia Healthcare Sector
* Kasumi Haruta
UBS Investment Bank, Research Division - Analyst
* Koichi Mamegano
BofA Securities, Research Division - Analyst
* Miki Sogi
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research
Daiichi Sankyo Co Ltd
(FRA:D4S)
€
15.01
+0.29 (+1.94%)
Market Cap: 26.93 Bil
Enterprise Value: 25.57 Bil
PE Ratio: 20.42
PB Ratio: 3.13
GF Score: 80/100 Full Year 2024 Daiichi Sankyo Co Ltd Earnings Presentation Transcript
Apr 25, 2024 / 06:00AM GMT
Release Date Price:
€29.27
(+3.06%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot